Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-24
1998-11-10
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 19, 514561, 514677, A61K 3800, A61K 31445, A61K 3195, A61K 3112
Patent
active
058344870
ABSTRACT:
This invention is a method for inhibiting cell proliferation using indanones.
REFERENCES:
patent: 5409944 (1995-04-01), Black et al.
patent: 5457237 (1995-10-01), Dow
Coux et al., Annu. Rev. Biochem., vol. 65, pp. 801-847, Structure and Functions of the 20S and 26S Proteasomes (1996).
Lowe et al., Science, vol. 268, pp. 533-539, Research Article, Crystal Structure of the 20S Proteasome from the Archaeon T. acidophilum at 3.4 .ANG. Resolution (1995.
Dahlmann et al., FEBS Letters, vol. 251, No. 1,2, pp. 125-131, The Multicatalytic Proteinase (prosome) is Ubiquitous From Eukaryotes to Archaebacteria (1989).
Seemuller et al., FEBS Letters, vol. 359, pp. 173-178, The Proteasome From Thermoplasma Acidophium is Neither a Cysteine Nor a Serine Protease (1995).
Orlowski, Biochemistry, vol. 29, No. 45, pp. 10289-10297, The Multicatalytic Proteinase Complex, a Major Extralysosomal Proteolytic System (1990).
Orlowski et al., Biochemistry, vol. 32, pp. 1563-1572, Evidence for the Presence of Five Distinct Proteolytic Components in the Pituitary Multicatalytic Proteinase Branched Chain and Small Neutral Amino Acids (1993).
Vinitsky et al., Biochemistry, vol. 31, pp. 9421-9428, Inhibition of the Chymotrypsin-like Activity of the Pituitary Multicatalytic Proteinase Complex (1992).
Tsubuki et al., Biochemical and Biophysical Research Communications, vol. 196, Degrading Protease Expected to Regulate Neurite Formation: A Novel Catalytic Activity in Proteasome (1993).
Rock et al., Cell, vol. 78, pp. 761-771, Inhibitors of the Proteasome Block the Degradation of Most Cell Proteins and the Generation of Peptides Presented on MHC Class I Molecules (1994).
Iqbal et al., J. Med. Chem., vol. 38, pp. 2276-2277, Potent Inhibitors of Proteasome (1995).
Iqbal et al., Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 3, pp. 287-290, Potent .varies.-Ketocarbonyl and Boronic Ester Derived Inhibitors of Proteasome (1996).
Fenteany et al., Science, vol. 268, pp. 726-731, Inhibition of Proteasome Activities and Subunit-Specific Amino-Terminal Threonine Modification by Lactacystin (1995).
Omura et al., The Journal of Antibiotics, vol. 44, No. 1, pp. 117-118, Structure of Neuroblastoma Cells (1990).
Fenteany et al., Proc. Natl. Acad. Sci, USA, vol. 91, pp. 3358-3362, A .beta.-Lactone Related to Lactacystin Induces Neurite Outgrowth in a Neuroblastoma Cell-Line and Inhibits Cell Cycle Progression in an Osteosarcoma Cell Line (1994).
Ciechanover, Cell, vol. 79, pp. 13-21, The Ubiquitin-Proteasome Proteolytic Pathway (1994).
Palombella et al., Cell, vol. 78, pp. 773-785, The Ubiquitin-Proteasome Pathway is Required for Processing the NF-.kappa.B1 Precursor Protein and the Activatiion of NF-.kappa.B (1994).
Ko et al., Genes & Development, vol. 10, pp. 1054-1072, p53: Puzzle and Paradigm (1996).
Oren, Seminars on Cancer Biology, vol. 5, pp. 221-227, Relationship of p. 53 to the Control of Apoptotic Cell Death (1991).
Joly Alison
Kerwar Suresh
Lum Robert T.
Nelson Marek G.
Schow Steven R.
Criares Theodore J.
CV Therapeutics
LandOfFree
Inhibition of 26S and 20S proteasome by indanones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of 26S and 20S proteasome by indanones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of 26S and 20S proteasome by indanones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517121